GeneDx Holdings (WGS) Free Cash Flow Growth (3y) (2023 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 53.76% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 10.52% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 8.16% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 11.42% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 28.22% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 34.71% |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | 10.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.86% |
| Mar 31, 2026 | 11.80% |
| Dec 31, 2025 | 51.53% |
| Sep 30, 2025 | 28.18% |
| Jun 30, 2025 | 27.92% |
| Mar 31, 2025 | 27.00% |
| Dec 31, 2024 | 51.94% |
| Sep 30, 2024 | 58.62% |
| Jun 30, 2024 | 41.01% |
| Mar 31, 2024 | 27.98% |
| Dec 31, 2023 | -65.04% |
| Sep 30, 2023 | -383.47% |